MREO Mereo BioPharma Group plc - American Depositary Shares
$0,31
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 11, 2026
Rango 52S
$0–$2
5% of range
Calificación del Analista
STRONG BUY
14 analysts
Precio Objetivo
$2
+540% upside
P/E (TTM)
-6.2
ROE
-88.1%
Margen de Beneficio Neto
-8375.6%
MREO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.31
Capitalización Bursátil
$248M
P/E (TTM)
-6.2
BPA (TTM)
$-0.05
Ingresos (TTM)
$500.0K
Rendimiento div.
—
ROE
-88.1%
Deuda/Capital
—
Rango 52S
$0 – $2
MREO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$500.0K
2022-12-31
→
2025-12-31
BPA
$-0.05
2022-12-31
→
2025-12-31
Flujo de caja libre
$-31M
2023-12-31
→
2025-12-31
Márgenes
-8375.6%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
MREO
Mediana de Pares
P/E (TTM)
-6.2
—
P/S (TTM) (P/V (TTM))
495.8
1305.2
P/B (P/C)
6.1
4.4
Price / FCF (Precio / FCF)
-8.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
MREO
Mediana de Pares
Operating Margin (Margen Operativo)
-8021.4%
—
Net Profit Margin (Margen de Beneficio Neto)
-8375.6%
-1841.7%
ROA
-68.5%
-38.9%
ROE
-88.1%
-49.6%
ROIC
-98.0%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
MREO
Mediana de Pares
Current Ratio (Ratio corriente)
10.5
10.5
Quick Ratio (Ratio Rápido)
9.5
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
MREO
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
MREO
Mediana de Pares
MREO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
14 analistas
- Compra fuerte 5 35,7%
- Compra 5 35,7%
- Mantener 4 28,6%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-13
Mediana
$1.98
← Por Debajo de Todos los Objetivos
$0.31
Mín
$1.00
Máx
$3.00
Objetivo mediano
$1.98
+536,7%
Objetivo medio
$1.99
+539,8%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.03%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.01 | $-0.01 | 0.00% |
| 31 de diciembre de 2025 | $-0.01 | $-0.01 | 0.00% |
| 30 de septiembre de 2025 | $-0.01 | $-0.02 | 0.01% |
| 30 de junio de 2025 | $-0.10 | $-0.02 | -0.08% |
| 31 de marzo de 2025 | $-0.10 | $-0.01 | -0.09% |
| 31 de diciembre de 2024 | $-0.05 | $-0.01 | -0.04% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MREO | $332M | -8.3 | — | -8375.6% | -88.1% | — |
| OKYO | — | — | — | — | — | — |
| BRNS | $29M | -0.4 | 1766.5% | — | -65.0% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $500.0K | $0 | $10M | $0 | |
| R&D Expense | $18M | $21M | $17M | $29M | |
| SG&A Expense | $23M | $26M | $18M | $26M | |
| Operating Income | $-40M | $-47M | $-28M | $-54M | |
| Interest Expense | $255.0K | $1M | $3M | $4M | |
| Interest Income | $104.0K | $0 | $2M | $840.0K | |
| Other Non-op | $300.0K | $0 | $-10.0K | $1M | |
| Pretax Income | $-42M | $-43M | $-30M | $-43M | |
| Income Tax | $0 | $0 | $-532.0K | $-718.0K | |
| Net Income | $-42M | $-43M | $-29M | $-42M | |
| EPS (Basic) | $-0.05 | $-0.06 | $-0.04 | $-0.07 | |
| EPS (Diluted) | $-0.05 | $-0.06 | $-0.04 | $-0.07 | |
| Shares (Basic) | 797,119,632 | 739,624,264 | 659,453,921 | 603,196,403 | |
| Shares (Diluted) | 797,119,632 | 739,624,264 | 659,453,921 | 603,196,403 | |
| EBITDA | $-40M | $-47M | $-28M | · |
Balance general 22
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $70M | $57M | $68M | |
| Prepaid Expense | $3M | $2M | $5M | $5M | |
| Current Assets | $45M | $75M | $64M | $75M | |
| PP&E (Net) | $137.0K | $257.0K | $405.0K | $551.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | |
| Accum. Depreciation | $1M | $949.0K | $800.0K | $736.0K | |
| Intangibles | $516.0K | $643.0K | $1M | $0 | |
| Total Assets | $46M | $76M | $66M | $77M | |
| Accounts Payable | $1M | $2M | $2M | $3M | |
| Accrued Liabilities | $2M | $4M | $5M | $5M | |
| Current Liabilities | $4M | $14M | $9M | $24M | |
| Capital Leases | $0 | $187.0K | $906.0K | $1M | |
| Other Non-current Liabilities | $661.0K | $565.0K | $764.0K | $0 | |
| Total Liabilities | $5M | $15M | $16M | $26M | |
| Common Stock | $3M | $3M | $3M | $2M | |
| Paid-in Capital | $550M | $540M | $486M | $477M | |
| Retained Earnings | $-501M | $-463M | $-420M | $-405M | |
| Treasury Stock | · | $0 | $1M | $1M | |
| AOCI | $-11M | $-19M | $-17M | $-22M | |
| Stockholders' Equity | $41M | $61M | $51M | $51M | |
| Liabilities + Equity | $46M | $76M | $66M | $77M | |
| Shares Outstanding | 795,658,504 | 775,728,034 | 701,217,089 | 624,928,519 |
Flujo de Efectivo 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $8M | $7M | $5M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | |
| Amort. of Intangibles | $465.0K | $438.0K | $395.0K | $0 | |
| Operating Cash Flow | $-31M | $-33M | $-21M | $-49M | |
| CapEx | $20.0K | $0 | $0 | $13.0K | |
| Investing Cash Flow | $-20.0K | $-699.0K | $-419.0K | $2M | |
| Stock Issued | $39.0K | $47M | $12M | $0 | |
| Net Stock Activity | $39.0K | $47M | $12M | · | |
| Financing Cash Flow | $327.0K | $46M | $8M | $200.0K | |
| Net Change in Cash | · | $12M | $-11M | · | |
| Taxes Paid | · | $0 | $-1M | $2M | |
| Free Cash Flow | $-31M | · | $-21M | · | |
| Levered FCF | $-31M | · | $-24M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -8021.4% | · | -284.2% | · | |
| Net Margin | -8375.6% | · | -294.7% | · | |
| Pretax Margin | -8375.6% | · | -300.0% | · | |
| EBITDA Margin | -8021.4% | · | -284.2% | · | |
| ROA | -68.5% | -60.5% | -40.9% | · | |
| ROE | -88.1% | 747.9% | -56.0% | · | |
| ROIC | -98.0% | -77.7% | -55.2% | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.5 | 5.4 | 6.7 | · | |
| Quick Ratio | 9.5 | 5.0 | 6.1 | · | |
| Interest Coverage | -157.3 | -34.6 | -9.9 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $500.0K | $0 | $10M | · | |
| Net Income TTM | $-42M | $-43M | $-29M | · | |
| Market Cap | $332M | $2.72B | $1.62B | · | |
| P/E | -8.3 | -58.3 | -57.8 | · | |
| P/S | 663.6 | · | 162.0 | · | |
| P/B | 8.1 | 44.5 | 32.1 | · | |
| P / Tangible Book | 8.2 | 45.0 | 32.8 | · | |
| P / Cash Flow | -10.7 | -82.7 | -76.7 | · | |
| P / FCF | -10.7 | · | -76.7 | · | |
| Earnings Yield | -12.0% | -1.7% | -1.7% | · |
Estado de resultados 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | $0 | $0 | $500.0K | · | $0 | $0 | $0 | $0 | $1M | $0 | $9M | $0 | |
| R&D Expense | $2M | $5M | $4M | $4M | $5M | $4M | $9M | $3M | $5M | $4M | $5M | $4M | $4M | $5M | |
| SG&A Expense | $5M | $4M | $4M | $6M | $5M | $7M | $6M | $6M | $8M | $6M | $4M | $6M | $3M | $6M | |
| Operating Income | $-7M | $-9M | $-8M | $-10M | $-10M | $-11M | $-15M | $-9M | $-13M | $-10M | $-7M | $-9M | $-811.0K | $-11M | |
| Interest Expense | $16.0K | $20.0K | $23.0K | $28.0K | $24.0K | $180.0K | $376.0K | $353.0K | $331.0K | $310.0K | $352.0K | $700.0K | $1M | $800.0K | |
| Interest Income | $19.0K | $31.0K | $70.0K | $-1M | $589.0K | $0 | $-2M | $983.0K | $559.0K | $617.0K | $763.0K | $689.0K | $373.0K | $306.0K | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-4.0K | $0 | $0 | $-6.0K | |
| Pretax Income | $-7M | $-7M | $-7M | $-7M | $-15M | $-13M | $-7M | $-15M | $-12M | $-9M | $-10M | $-7M | $-2M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-532.0K | $0 | $0 | $0 | |
| Net Income | $-7M | $-7M | $-7M | $-7M | $-15M | $-13M | $-7M | $-15M | $-12M | $-9M | $-9M | $-7M | $-2M | $-12M | |
| EPS (Basic) | $-0.01 | $-0.01 | $0.00 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.02 | |
| EPS (Diluted) | $-0.01 | $-0.01 | $0.00 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.02 | |
| Shares (Basic) | 803,562,708 | 801,805,570 | -1,586,542,097 | 799,947,013 | 799,435,329 | 784,279,387 | -1,500,932,404 | 770,146,589 | 770,146,589 | 700,263,490 | -1,277,866,968 | 684,974,190 | 628,421,064 | 623,925,635 | |
| Shares (Diluted) | 803,562,708 | 801,805,570 | -1,586,542,097 | 799,947,013 | 799,435,329 | 784,279,387 | -1,500,932,404 | 770,146,589 | 770,146,589 | 700,263,490 | -1,277,866,968 | 684,974,190 | 628,421,064 | 623,925,635 | |
| EBITDA | $-7M | $-9M | · | $-10M | $-10M | $-11M | · | $-9M | $-13M | $-10M | · | · | · | · |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $36M | $41M | $49M | $56M | $62M | $70M | $81M | $87M | $49M | $57M | · | · | · | |
| Prepaid Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $4M | $4M | $3M | $5M | · | · | · | |
| Current Assets | $33M | $40M | $45M | $52M | $61M | $67M | $75M | $87M | $94M | $53M | $64M | · | · | · | |
| PP&E (Net) | $54.0K | $91.0K | $137.0K | $174.0K | $218.0K | $247.0K | $257.0K | $315.0K | $338.0K | $360.0K | $405.0K | · | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | |
| Accum. Depreciation | $1M | $978.0K | $1M | $1M | $1M | $1M | $949.0K | $964.0K | $877.0K | $836.0K | $800.0K | · | · | · | |
| Intangibles | $256.0K | $381.0K | $516.0K | $643.0K | $470.0K | $554.0K | $643.0K | $799.0K | $866.0K | $972.0K | $1M | · | · | · | |
| Total Assets | $35M | $41M | $46M | $54M | $63M | $68M | $76M | $89M | $96M | $56M | $66M | · | · | · | |
| Accounts Payable | $1M | $3M | $1M | $879.0K | $1M | $3M | $2M | $2M | $3M | $2M | $2M | · | · | · | |
| Accrued Liabilities | $2M | $2M | $2M | $4M | $5M | $3M | $4M | $4M | $4M | $3M | $5M | · | · | · | |
| Current Liabilities | $6M | $6M | $4M | $6M | $8M | $7M | $14M | $14M | $15M | $11M | $9M | · | · | · | |
| Capital Leases | $0 | · | $0 | $0 | $0 | $0 | $187.0K | $394.0K | $552.0K | $727.0K | $906.0K | · | · | · | |
| Other Non-current Liabilities | $370.0K | $362.0K | $661.0K | $652.0K | $352.0K | $325.0K | $565.0K | $568.0K | $536.0K | $513.0K | $764.0K | · | · | · | |
| Total Liabilities | $6M | $7M | $5M | $7M | $8M | $8M | $15M | $16M | $17M | $13M | $16M | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | · | · | |
| Paid-in Capital | $552M | $551M | $550M | $548M | $546M | $544M | $540M | $536M | $535M | $487M | $486M | · | · | · | |
| Retained Earnings | $-515M | $-508M | $-501M | $-494M | $-487M | $-472M | $-463M | $-456M | $-441M | $-429M | $-420M | · | · | · | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $0 | $0 | $1M | · | · | · | |
| AOCI | $-12M | $-13M | $-11M | $-11M | $-9M | $-15M | $-19M | $-11M | $-18M | $-18M | $-17M | · | · | · | |
| Stockholders' Equity | $29M | $34M | $41M | $47M | $54M | $60M | $61M | $73M | $79M | $43M | $51M | · | · | · | |
| Liabilities + Equity | $35M | $41M | $46M | $54M | $63M | $68M | $76M | $89M | $96M | $56M | $66M | · | · | · | |
| Shares Outstanding | 798,093,044 | 798,078,829 | 795,658,504 | 795,484,404 | 795,001,444 | 795,001,444 | 775,728,034 | 773,672,299 | 768,821,274 | 701,349,434 | 701,217,089 | · | · | · |
Flujo de Efectivo 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $815.0K | $2M | $941.0K | $2M | |
| Amort. of Intangibles | $127.0K | $127.0K | $424.0K | $-183.0K | $118.0K | $106.0K | $110.0K | $112.0K | $108.0K | $108.0K | $115.0K | $109.0K | $107.0K | $64.0K | |
| Operating Cash Flow | $-6M | $-4M | $-8M | $-7M | $-8M | $-8M | $-9M | $-8M | $-8M | $-8M | $-7M | $3M | $-8M | $-9M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $20.0K | $0 | $0 | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $0 | $-300.0K | $0 | $300.0K | $0 | $-320.0K | $0 | $0 | $1.0K | $-700.0K | $0 | $0 | $0 | $-419.0K | |
| Stock Issued | · | · | $39.0K | $0 | · | · | $0 | $0 | · | · | $0 | $12M | · | · | |
| Financing Cash Flow | $0 | $0 | $39.0K | $0 | $-134.0K | $422.0K | $-40.0K | $-594.0K | $47M | $0 | $0 | $8M | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | |
| Taxes Paid | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $37.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-8M | · | · | · | · | · | · | · | · | |
| Levered FCF | · | $-4M | · | · | · | $-9M | · | · | · | · | · | · | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2099.8% | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | -2923.2% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | -2923.2% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -2099.8% | · | · | · | · | · | · | · | · | · | |
| ROA | -14.4% | -12.3% | · | -9.9% | -18.4% | -20.7% | · | -33.8% | -25.5% | -32.0% | · | · | · | · | |
| ROE | -16.9% | -14.3% | · | -11.8% | -22.0% | -25.0% | · | -41.4% | -31.2% | -41.8% | · | · | · | · | |
| ROIC | -24.5% | -25.7% | · | -21.5% | -19.4% | -18.6% | · | -12.9% | -16.3% | -23.1% | · | · | · | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.5 | · | 8.7 | 8.1 | 8.9 | · | 6.1 | 6.1 | 4.9 | · | · | · | · | |
| Quick Ratio | 5.3 | 5.9 | · | 8.1 | 7.4 | 8.3 | · | 5.7 | 5.7 | 4.4 | · | · | · | · | |
| Interest Coverage | -439.4 | -438.3 | · | -357.7 | -437.5 | -62.2 | · | -26.6 | -38.7 | -31.9 | · | · | · | · |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $0 | · | $0 | $9M | $9M | · | · | · | · | |
| Net Income TTM | $-35M | $-41M | · | $-50M | $-55M | $-49M | · | $-43M | $-29M | $-29M | · | · | · | · | |
| Market Cap | $254M | $263M | · | $1.64B | $2.15B | $1.79B | · | $3.18B | $2.77B | $2.31B | · | · | · | · | |
| P/E | -6.4 | -5.5 | · | -29.4 | -33.9 | -32.1 | · | -68.5 | -90.0 | -82.5 | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | 307.5 | 257.2 | · | · | · | · | |
| P/B | 8.9 | 7.7 | · | 35.2 | 39.8 | 29.8 | · | 43.8 | 35.2 | 54.0 | · | · | · | · | |
| P / Tangible Book | 8.9 | 7.8 | · | 35.7 | 40.1 | 30.0 | · | 44.3 | 35.6 | 55.3 | · | · | · | · | |
| P / Cash Flow | · | -61.1 | · | · | · | -214.8 | · | · | · | -289.6 | · | · | · | · | |
| P / FCF | · | -61.1 | · | · | · | -214.2 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -15.7% | -18.2% | · | -3.4% | -2.9% | -3.1% | · | -1.5% | -1.1% | -1.2% | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Ingresos | $500.0K | $0 | $10M | $0 |
| Margen Operativo % | -8021.4% | — | -284.2% | — |
| Beneficio neto | $-42M | $-43M | $-29M | $-42M |
| EPS Diluido | $-0.05 | $-0.06 | $-0.04 | $-0.07 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Ratio corriente | 10.5 | 5.4 | 6.7 | — |
| Ratio Rápido | 9.5 | 5.0 | 6.1 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Flujo de caja libre | $-31M | — | $-21M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 68 declarantes · $17.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 15 (-1 vs trimestre anterior) | 17 (-6 vs trimestre anterior) | 15 (-3 vs trimestre anterior) | 15 (0 vs trimestre anterior) | -18.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Rubric Capital Management LP | $4 863 144 | 15 307 347 | 27,62% | Acciones |
| 683 Capital Management, LLC | $3 741 825 | 11 777 856 | 21,25% | Acciones |
| BANK OF AMERICA CORP /DE/ | $2 597 904 | 8 195 281 | 14,75% | Acciones |
| Defilade Capital Management, L.P. | $2 401 417 | 7 558 756 | 13,64% | Acciones |
| Newtyn Management, LLC | $953 100 | 3 000 000 | 5,41% | Acciones |
| Tejara Capital Ltd | $647 320 | 2 037 520 | 3,68% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $419 123 | 1 319 241 | 2,38% | Acciones |
| EcoR1 Capital, LLC | $317 700 | 1 000 000 | 1,80% | Acciones |
| Ishara Investments LP | $244 232 | 768 750 | 1,39% | Acciones |
| Wealthspire Advisors, LLC | $243 041 | 765 000 | 1,38% | Acciones |
| CITADEL ADVISORS LLC | $160 407 | 504 900 | 0,91% | Opción de compra |
| JANE STREET GROUP, LLC | $154 711 | 486 971 | 0,88% | Acciones |
| TWO SIGMA ADVISERS, LP | $104 967 | 251 900 | 0,60% | Acciones |
| Rangeley Capital, LLC | $104 587 | 329 200 | 0,59% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $67 756 | 213 270 | 0,38% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55 520 | 173 500 | 0,32% | Opción de compra |
| XTX Topco Ltd | $55 433 | 174 481 | 0,31% | Acciones |
| GROUP ONE TRADING LLC | $53 220 | 167 515 | 0,30% | Acciones |
| STATE STREET CORP | $42 817 | 134 772 | 0,24% | Acciones |
| Sheets Smith Investment Management | $34 793 | 16 890 | 0,20% | Acciones |
| NOMURA HOLDINGS INC | $33 155 | 104 361 | 0,19% | Acciones |
| James J. Burns & Company, LLC | $30 309 | 95 400 | 0,17% | Acciones |
| Quarry LP | $29 784 | 93 750 | 0,17% | Acciones |
| GOLDMAN SACHS GROUP INC | $27 062 | 85 180 | 0,15% | Acciones |
| JMN Financial LLC | $24 383 | 76 748 | 0,14% | Acciones |
| BlackRock, Inc. | $22 137 | 69 678 | 0,13% | Acciones |
| JPMORGAN CHASE & CO | $18 887 | 56 923 | 0,11% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $16 552 | 52 100 | 0,09% | Acciones |
| CITADEL ADVISORS LLC | $16 203 | 51 000 | 0,09% | Opción de venta |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14 720 | 46 000 | 0,08% | Opción de venta |
| MARSHALL WACE, LLP | $10 532 | 32 913 | 0,06% | Acciones |
| Significant Wealth Partners LLC | $10 382 | 32 677 | 0,06% | Acciones |
| Clear Harbor Asset Management, LLC | $10 083 | 32 000 | 0,06% | Acciones |
| RHUMBLINE ADVISERS | $8 511 | 26 784 | 0,05% | Acciones |
| Centiva Capital, LP | $7 943 | 25 000 | 0,05% | Acciones |
| Engineers Gate Manager LP | $7 610 | 23 953 | 0,04% | Acciones |
| SIMPLEX TRADING, LLC | $5 972 | 18 780 | 0,03% | Acciones |
| NFSG Corp | $5 957 | 18 750 | 0,03% | Acciones |
| OneDigital Investment Advisors LLC | $5 814 | 18 300 | 0,03% | Acciones |
| IHT Wealth Management, LLC | $4 766 | 15 000 | 0,03% | Acciones |
| CITADEL ADVISORS LLC | $4 250 | 13 378 | 0,02% | Acciones |
| TWO SIGMA SECURITIES, LLC | $4 098 | 12 900 | 0,02% | Acciones |
| J. Safra Sarasin Holding AG | $4 081 | 12 841 | 0,02% | Acciones |
| MML INVESTORS SERVICES, LLC | $3 876 | 12 200 | 0,02% | Acciones |
| JANE STREET GROUP, LLC | $3 749 | 11 800 | 0,02% | Opción de compra |
| World Investment Advisors | $3 300 | 10 000 | 0,02% | Acciones |
| Astoria Portfolio Advisors LLC. | $3 177 | 10 000 | 0,02% | Acciones |
| GAMMA Investing LLC | $2 957 | 9 308 | 0,02% | Acciones |
| UBS Group AG | $1 880 | 5 912 | 0,01% | Acciones |
| Arax Advisory Partners | $1 849 | 5 819 | 0,01% | Acciones |
| Rockefeller Capital Management L.P. | $635 | 2 000 | 0,00% | Acciones |
| Allworth Financial LP | $477 | 1 500 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $320 | 1 000 | 0,00% | Acciones |
| New England Capital Financial Advisors LLC | $96 | 300 | 0,00% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $71 | 225 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $36 | 114 | 0,00% | Acciones |
| EverSource Wealth Advisors, LLC | $32 | 100 | 0,00% | Acciones |
| Virtu Financial LLC | $19 | 61 285 | 0,00% | Acciones |
| CITIGROUP INC | $17 | 52 | 0,00% | Acciones |
| US BANCORP \DE\ | $4 | 13 | 0,00% | Acciones |
| SG Americas Securities, LLC | $4 | 12 802 | 0,00% | Acciones |
| MORGAN STANLEY | $1 | 1 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 | 3 | 0,00% | Acciones |
| Integrated Wealth Concepts LLC | $0 | 1 | 0,00% | Acciones |
| Axiom Investment Management LLC | $0 | 1 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $0 | 1 | 0,00% | Acciones |
| SIT INVESTMENT ASSOCIATES INC | $0 | 970 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $0 | 1 | 0,00% | Acciones |
Informantes de la empresa 13 insiders · 5 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Denise Scots-Knight | Chief Executive Officer | 1 de febrero de 2026 A | 808 921 | 0 | 0 | $0 |
| Chrisitne Ann Fox | Chief Financial Officer | 1 de febrero de 2026 A | 89 285 | 0 | 0 | $0 |
| Alexandra Hughes-Wilson | Chief Patient Access and Commercial Planning | 1 de febrero de 2026 A | 50 475 | 0 | 0 | $0 |
| Charles Sermon | General Counsel | 1 de febrero de 2026 A | 219 061 | 0 | 0 | $0 |
| John A. Lewicki | Chief Scientific Officer | 1 de febrero de 2026 A | 78 630 | 0 | 0 | $0 |
| Anders Ekblom | Consejero | 26 de febrero de 2026 A | — | 0 | 0 | $0 |
| Daniel Shames | Consejero | 26 de febrero de 2026 A | — | 0 | 0 | $0 |
| Jeremy Bender | Consejero | 26 de febrero de 2026 A | 12 550 | 0 | 0 | $0 |
| Pierre Jacquet | Consejero | 26 de febrero de 2026 A | — | 0 | 0 | $0 |
| Annalisa Jenkins | Consejero | 26 de febrero de 2026 A | — | 0 | 0 | $0 |
| Marc J Yoskowitz | Consejero | 26 de febrero de 2026 A | — | 0 | 0 | $0 |
| Deepika Pakianathan | Consejero | 26 de febrero de 2026 A | 0 | 0 | 0 | $0 |
| Michael S Wyzga | Consejero | 26 de febrero de 2026 A | 25 050 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×16 presentaciones | 17 de junio de 2024 | — | Presentación inicial | — | SEC |
| Mereo BioPharma Group plc, Dr. Denise Scots-Knight | 17 de diciembre de 2018 | — | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,09% | 127 193 NS | 30 de abril de 2026 | N-PORT |